Literature DB >> 1336057

Constitutional ring chromosomes and tumour suppressor genes.

N Tommerup1, R Lothe.   

Abstract

The types of malignancy reported in carriers of constitutional ring chromosomes r(11), r(13), and r(22) are concordant with the chromosomal assignment of tumour suppressor loci associated with Wilms' tumour, retinoblastoma, and meningioma. It is suggested that the somatic instability of ring chromosomes may play a role in this association and that constitutional ring chromosomes may be a source for mapping of tumour suppressor loci with the potential for covering most or all of the human genome. The hypothesis predicts the presence of a locus on chromosome 10 associated with follicular carcinoma of the thyroid, in line with previous cytogenetic findings of rearrangements involving chromosome 10 in thyroid tumours, and a locus on chromosome 22 associated with testicular cancer. Development of neurofibromatoses (NF) that do not fulfil the clinical criteria of neurofibromatosis type 2 (NF2) in carriers with r(22) suggests either the presence of an additional NF locus on chromosome 22 or that ring chromosome mediated predisposition to somatic mutation of a specific tumour suppressor may be associated with atypical development of features usually associated with germline mutations.

Entities:  

Mesh:

Year:  1992        PMID: 1336057      PMCID: PMC1016205          DOI: 10.1136/jmg.29.12.879

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  43 in total

1.  Loss of constitutional heterozygosity in colon carcinoma from patients with familial polyposis coli.

Authors:  M Okamoto; M Sasaki; K Sugio; C Sato; T Iwama; T Ikeuchi; A Tonomura; T Sasazuki; M Miyaki
Journal:  Nature       Date:  1988-01-21       Impact factor: 49.962

2.  Chromosomal imbalance in the Aniridia-Wilms' tumor association: 11p interstitial deletion.

Authors:  V M Riccardi; E Sujansky; A C Smith; U Francke
Journal:  Pediatrics       Date:  1978-04       Impact factor: 7.124

3.  Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22.

Authors:  G A Rouleau; B R Seizinger; W Wertelecki; J L Haines; D W Superneau; R L Martuza; J F Gusella
Journal:  Am J Hum Genet       Date:  1990-02       Impact factor: 11.025

4.  Ring chromosome 4.

Authors:  A McDermott; M A Voyce; D Romain
Journal:  J Med Genet       Date:  1977-06       Impact factor: 6.318

5.  A translocation (7;10)(q35;q21) in a differentiated papillary carcinoma of the thyroid.

Authors:  P Antonini; A M Venuat; G Linares; B Caillou; R Berger; C Parmentier
Journal:  Cancer Genet Cytogenet       Date:  1989-08

6.  Molecular genetic analysis of chromosome 22 in 81 cases of meningioma.

Authors:  J P Dumanski; G A Rouleau; M Nordenskjöld; V P Collins
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

7.  Ring 10 chromosome: 46,XX,r10(p15q26).

Authors:  R S Sparkes; S M Ling; H Muller
Journal:  Hum Genet       Date:  1978-09-19       Impact factor: 4.132

8.  Sequence homology shared by neurofibromatosis type-1 gene and IRA-1 and IRA-2 negative regulators of the RAS cyclic AMP pathway.

Authors:  A M Buchberg; L S Cleveland; N A Jenkins; N G Copeland
Journal:  Nature       Date:  1990-09-20       Impact factor: 49.962

Review 9.  Tumor suppressor genes.

Authors:  R A Weinberg
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

10.  A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10.

Authors:  C G Mathew; K S Chin; D F Easton; K Thorpe; C Carter; G I Liou; S L Fong; C D Bridges; H Haak; A C Kruseman
Journal:  Nature       Date:  1987 Aug 6-12       Impact factor: 49.962

View more
  11 in total

Review 1.  Mendelian cytogenetics. Chromosome rearrangements associated with mendelian disorders.

Authors:  N Tommerup
Journal:  J Med Genet       Date:  1993-09       Impact factor: 6.318

2.  A newborn with ring chromosome 10, aganglionic megacolon, and renal hypoplasia.

Authors:  G Calabrese; P G Franchi; L Stuppia; R Mingarelli; C Rossi; L Ramenghi; M Marino; E Morizio; R Peila; A Antonucci
Journal:  J Med Genet       Date:  1994-10       Impact factor: 6.318

3.  Atypical teratoid rhabdoid brain tumor in an infant with ring chromosome 22.

Authors:  Eun Hae Cho; Jae Bok Park; Jin Kyung Kim
Journal:  Korean J Pediatr       Date:  2014-07-23

4.  Deletions of the long arm of chromosome 10 in progression of follicular thyroid tumors.

Authors:  J Zedenius; G Wallin; A Svensson; J Bovèe; A Höög; M Bäckdahl; C Larsson
Journal:  Hum Genet       Date:  1996-03       Impact factor: 4.132

5.  Metachromatic leucodystrophy (MLD) in a patient with a constitutional ring chromosome 22.

Authors:  M B Coulter-Mackie; J Rip; M D Ludman; J Beis; D E Cole
Journal:  J Med Genet       Date:  1995-10       Impact factor: 6.318

6.  Allelotyping of follicular thyroid tumors.

Authors:  J Zedenius; G Wallin; A Svensson; L Grimelius; A Höög; G Lundell; M Bäckdahl; C Larsson
Journal:  Hum Genet       Date:  1995-07       Impact factor: 4.132

7.  Dysregulation of FOXG1 by ring chromosome 14.

Authors:  Daniela Alosi; Laura Line Klitten; Mads Bak; Helle Hjalgrim; Rikke Steensbjerre Møller; Niels Tommerup
Journal:  Mol Cytogenet       Date:  2015-04-09       Impact factor: 2.009

8.  Ring chromosome 22: a review of the literature and first report from India.

Authors:  S Mahajan; A Kaur; J Singh
Journal:  Balkan J Med Genet       Date:  2012-06       Impact factor: 0.519

9.  Cell-autonomous correction of ring chromosomes in human induced pluripotent stem cells.

Authors:  Marina Bershteyn; Yohei Hayashi; Guillaume Desachy; Edward C Hsiao; Salma Sami; Kathryn M Tsang; Lauren A Weiss; Arnold R Kriegstein; Shinya Yamanaka; Anthony Wynshaw-Boris
Journal:  Nature       Date:  2014-01-12       Impact factor: 49.962

10.  Pathogenesis of vestibular schwannoma in ring chromosome 22.

Authors:  Ellen Denayer; Hilde Brems; Paul de Cock; Gareth D Evans; Frank Van Calenbergh; Naomi Bowers; Raf Sciot; Maria Debiec-Rychter; Joris V Vermeesch; Jean-Pierre Fryns; Eric Legius
Journal:  BMC Med Genet       Date:  2009-09-22       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.